Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_assertion description "[Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_assertion evidence source_evidence_literature NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_assertion SIO_000772 23396606 NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_assertion wasDerivedFrom befree-2016 NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_assertion wasGeneratedBy ECO_0000203 NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1051677.RAHPaaBYBjtxQa0sBpLx1d1YRRnBNouCq3bqZgP6DfCWQ130_provenance.